Diabetes Mellitus Type 1 Clinical Trial
Official title:
The Effect of Supplementation With Two Different Doses of Vitamin D (500 IU vs 1000IU)on Bone Mineral Density, Serum 25 Hydroxyvitamin D and Hand Grip Strength in Children With Diabetes Mellitus Type 1 - a Randomized Controlled Trial.
The aim of the study is to assess the effect of 12 month supplementation with two different
doses of vitamin D ( 500 vs 1000) on bone mineral density, serum 25 hydroxyvitamin D levels
and hand grip strength in preadolescents with diabetes mellitus type 1.
100 children in the of age 8 -11 with diabetes mellitus type 1 lasting for more than 3
months, without history of diabetic ketoacidosis during previous month, without other
chronic disease which may affect calcium-phosphorus metabolism will be randomized in a
double blind controlled trial to supplement them with either 500 IU or 1000 IU vitamin D.
Every 3 months, in spring summer,autumn and winter serum level of calcium,25-hydroxyvitamin
D level and HbA1c will be measured. At the entry and at the end of the study patients will
have total body and lumbar spine bone mineral density assessment. Every six months hand grip
strength will be measured. Additionally at the beginning and after 12 mo of supplementation
and at the beginning serum levels of TNF-alfa, osteoprotegerin and IL-6 will be assessed.
Evidence indicates that majority (75-90%) of children with diabetes have lower serum
concentrations of vitamin D, which may negatively impacts bone health and can be associated
with reduction of muscular strength. There is still unknown what is the optimal dose of
vitamin D in these patients for adequate supply of vitamin D throughout the year to assure
optimal peak bone mass and muscle strengthThe aim of the study is to assess the effect of 12
month supplementation with two different doses of vitamin D ( 500 vs 1000) on bone mineral
density, serum 25 hydroxyvitamin D levels and hand grip strength in preadolescents with
diabetes mellitus type 1.
100 children in the of age 8 -11 with diabetes mellitus type 1 lasting for more than 3
months, without history of diabetic ketoacidosis during previous month, without other
chronic disease which may affect calcium-phosphorus metabolism will be randomized in a
double blind controlled trial to supplement them with either 500 IU or 1000 IU vitamin D.
Every 3 months, in spring summer,autumn and winter serum level of calcium,25-hydroxyvitamin
D level and HbA1c will be measured. At the entry and at the end of the study patients will
have total body and lumbar spine bone mineral density assessment. Every six months hand grip
strength will be measured. Additionally at the beginning and after 12 mo of supplementation
and at the beginning serum levels of TNF-alfa, osteoprotegerin and IL-6 will be assessed.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01508065 -
Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device
|
||
| Completed |
NCT01788033 -
Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
|
Phase 2 | |
| Active, not recruiting |
NCT01271517 -
Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
|
Phase 4 | |
| Recruiting |
NCT01800734 -
Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study
|
Phase 4 | |
| Recruiting |
NCT06088615 -
Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry
|
||
| Completed |
NCT02127047 -
Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
|
Phase 2 | |
| Completed |
NCT01689090 -
Diameter Changes of Retinal Vessels During Hypoxia
|
N/A | |
| Completed |
NCT00006505 -
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
|
Phase 2 | |
| Not yet recruiting |
NCT06217302 -
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
|
Phase 3 | |
| Recruiting |
NCT02750111 -
Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes
|
N/A | |
| Recruiting |
NCT02545062 -
MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes
|
N/A | |
| Completed |
NCT02146651 -
A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
|
Phase 2 | |
| Completed |
NCT02538120 -
Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients
|
N/A | |
| Completed |
NCT02403375 -
Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes
|
N/A | |
| Terminated |
NCT00896610 -
Natural History of Autoimmune Diabetes and Its Complications
|
||
| Terminated |
NCT02701257 -
The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
|
N/A | |
| Completed |
NCT02094534 -
A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics
|
Phase 2 | |
| Completed |
NCT01334151 -
Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes
|
Phase 1 | |
| Active, not recruiting |
NCT02624804 -
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
|
Phase 1 | |
| Completed |
NCT02465411 -
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
|
N/A |